Correction to: Xanthohumol microbiome and signature in healthy adults (the XMaS trial): a phase I triple-masked, placebo-controlled clinical trial (Trials, (2020), 21, 1, (835), 10.1186/s13063-020-04769-2)

Ryan Bradley; Blake O. Langley; Jennifer J. Ryan; John Phipps; Douglas A. Hanes; Emily Stack; Janet K. Jansson; Thomas O. Metz; Jan Frederik Stevens

doi:10.1186/s13063-020-04834-w

Correction to: Xanthohumol microbiome and signature in healthy adults (the XMaS trial): a phase I triple-masked, placebo-controlled clinical trial (Trials, (2020), 21, 1, (835), 10.1186/s13063-020-04769-2)

Ryan Bradley, Blake O. Langley, Jennifer J. Ryan, John Phipps, Douglas A. Hanes, Emily Stack, Janet K. Jansson, Thomas O. Metz, Jan Frederik Stevens

Research output: Contribution to journal › Comment/debate

Abstract

Following publication of the original article [1], we were notified that in the first paragraph of the Interventions section (line 202), “Participants randomized to placebo will be administered 288 mg of rice protein, 133.4 mg microcrystalline cellulose” should read “Participants randomized to placebo will be administered 288 mg of rice protein,109.3 mg microcrystalline cellulose”. The original article has been corrected.

Original language	English
Article number	885
Journal	Trials
Volume	21
Issue number	1
DOIs	https://doi.org/10.1186/s13063-020-04834-w
State	Published - Dec 1 2020

Access to Document

10.1186/s13063-020-04834-w

Fingerprint

Dive into the research topics of 'Correction to: Xanthohumol microbiome and signature in healthy adults (the XMaS trial): a phase I triple-masked, placebo-controlled clinical trial (Trials, (2020), 21, 1, (835), 10.1186/s13063-020-04769-2)'. Together they form a unique fingerprint.

Cite this

Bradley, R., Langley, B. O., Ryan, J. J., Phipps, J., Hanes, D. A., Stack, E., Jansson, J. K., Metz, T. O., & Stevens, J. F. (2020). Correction to: Xanthohumol microbiome and signature in healthy adults (the XMaS trial): a phase I triple-masked, placebo-controlled clinical trial (Trials, (2020), 21, 1, (835), 10.1186/s13063-020-04769-2). Trials, 21(1), Article 885. https://doi.org/10.1186/s13063-020-04834-w

@article{4eae03d92f0047239e4eea12246a6e5f,

title = "Correction to: Xanthohumol microbiome and signature in healthy adults (the XMaS trial): a phase I triple-masked, placebo-controlled clinical trial (Trials, (2020), 21, 1, (835), 10.1186/s13063-020-04769-2)",

abstract = "Following publication of the original article [1], we were notified that in the first paragraph of the Interventions section (line 202), “Participants randomized to placebo will be administered 288 mg of rice protein, 133.4 mg microcrystalline cellulose” should read “Participants randomized to placebo will be administered 288 mg of rice protein,109.3 mg microcrystalline cellulose”. The original article has been corrected.",

author = "Ryan Bradley and Langley, {Blake O.} and Ryan, {Jennifer J.} and John Phipps and Hanes, {Douglas A.} and Emily Stack and Jansson, {Janet K.} and Metz, {Thomas O.} and Stevens, {Jan Frederik}",

note = "Publisher Copyright: {\textcopyright} 2020, The Author(s).",

year = "2020",

month = dec,

day = "1",

doi = "10.1186/s13063-020-04834-w",

language = "English",

volume = "21",

journal = "Trials",

issn = "1745-6215",

publisher = "BioMed Central Ltd.",

number = "1",

}

Bradley, R, Langley, BO, Ryan, JJ, Phipps, J, Hanes, DA, Stack, E, Jansson, JK, Metz, TO & Stevens, JF 2020, 'Correction to: Xanthohumol microbiome and signature in healthy adults (the XMaS trial): a phase I triple-masked, placebo-controlled clinical trial (Trials, (2020), 21, 1, (835), 10.1186/s13063-020-04769-2)', Trials, vol. 21, no. 1, 885. https://doi.org/10.1186/s13063-020-04834-w

Correction to: Xanthohumol microbiome and signature in healthy adults (the XMaS trial): a phase I triple-masked, placebo-controlled clinical trial (Trials, (2020), 21, 1, (835), 10.1186/s13063-020-04769-2). / Bradley, Ryan; Langley, Blake O.; Ryan, Jennifer J. et al.
In: Trials, Vol. 21, No. 1, 885, 01.12.2020.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Correction to

T2 - Xanthohumol microbiome and signature in healthy adults (the XMaS trial): a phase I triple-masked, placebo-controlled clinical trial (Trials, (2020), 21, 1, (835), 10.1186/s13063-020-04769-2)

AU - Bradley, Ryan

AU - Langley, Blake O.

AU - Ryan, Jennifer J.

AU - Phipps, John

AU - Hanes, Douglas A.

AU - Stack, Emily

AU - Jansson, Janet K.

AU - Metz, Thomas O.

AU - Stevens, Jan Frederik

PY - 2020/12/1

Y1 - 2020/12/1

N2 - Following publication of the original article [1], we were notified that in the first paragraph of the Interventions section (line 202), “Participants randomized to placebo will be administered 288 mg of rice protein, 133.4 mg microcrystalline cellulose” should read “Participants randomized to placebo will be administered 288 mg of rice protein,109.3 mg microcrystalline cellulose”. The original article has been corrected.

AB - Following publication of the original article [1], we were notified that in the first paragraph of the Interventions section (line 202), “Participants randomized to placebo will be administered 288 mg of rice protein, 133.4 mg microcrystalline cellulose” should read “Participants randomized to placebo will be administered 288 mg of rice protein,109.3 mg microcrystalline cellulose”. The original article has been corrected.

UR - http://www.scopus.com/inward/record.url?scp=85093867394&partnerID=8YFLogxK

U2 - 10.1186/s13063-020-04834-w

DO - 10.1186/s13063-020-04834-w

M3 - Comment/debate

C2 - 33106168

AN - SCOPUS:85093867394

SN - 1745-6215

VL - 21

JO - Trials

JF - Trials

IS - 1

M1 - 885

ER -

Correction to: Xanthohumol microbiome and signature in healthy adults (the XMaS trial): a phase I triple-masked, placebo-controlled clinical trial (Trials, (2020), 21, 1, (835), 10.1186/s13063-020-04769-2)

Abstract

Access to Document

Other files and links

Fingerprint

Cite this